Therapeutic Drug Monitoring for Sirolimus in Children with Vascular Anomalies: What Can We Learn from a Retrospective Study

• Main Authors: Ya-Hui Hu (Author), Yue-Tao Zhao (Author), Hong-Li Guo (Author), Yue Li (Author), Yuan-Yuan Zhang (Author), Jie Wang (Author), Xuan-Sheng Ding (Author), Ji-Jun Zou (Author), Feng Chen (Author)
• Format: Book
• Published: MDPI AG, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Objectives</b>: Sirolimus (SRL), a mammalian target of rapamycin inhibitor, has been widely used to treat patients with vascular anomalies (VAs). The objectives of this study were to summarize the routine blood SRL monitoring data for VAs children, to investigate the factors contribut...